Novel Mcl‐1/Bcl‐2 Dual Inhibitors Created by the Structure‐Based Hybridization of Drug‐Divided Building Blocks and a Fragment Deconstructed from a Known Two‐Face BH3 Mimetic

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-4184|348|2|89-99

ISSN： 0365-6233

Source： ARCHIV DER PHARMAZIE (ELECTRONIC), Vol.348, Iss.2, 2015-02, pp. : 89-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Based Drug Design for Dopamine D3 Receptor

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 15, Iss. 10, 2012-12 ,pp. : 775-791

Bentham Science Publishers

Access to resources Recommend Favorite

Novel MK2 Inhibitors by Fragment Screening

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 12, Iss. 7, 2009-08 ,pp. : 697-703

Bentham Science Publishers

Access to resources Recommend Favorite

Integrated pharmacophore and docking‐based designing of dual inhibitors of aldose reductase (ALR2) and protein tyrosine phosphatase 1B (PTP1B) as novel therapeutics for insulin‐resistant diabetes and its complications

By  

JOURNAL OF CHEMOMETRICS (ELECTRONIC), Vol. 29, Iss. 2, 2015-02 ,pp. : 109-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Structure-Based Drug Discovery for Plasmodium falciparum

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 8, Iss. 1, 2005-02 ,pp. : 5-14

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Drug Screening and Ligand-Based Drug Screening with Machine Learning

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 12, Iss. 4, 2009-05 ,pp. : 397-408

Bentham Science Publishers

Access to resources Recommend Favorite